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Abstract
Introduction: Paravertebral and paraspinal tumors pose a significant challenge in radiation therapy because of the
radiation sensitivity of the spinal cord and the need for maximum treatment accuracy. Implantation of fiducial
markers into vertebral bodies has been described as a method of increasing the accuracy of radiation treatment for
single-dose stereotactic radiosurgery for spinal and paraspinal primary tumors and metastases. However, utilization
of this technique has not been described for conventionally fractionated radiation therapy. This report is the first of
its kind in the literature and describes successful treatment of a T4 primary lung tumor with vertebral body
invasion with conventionally fractionated, image-guided radiotherapy using fiducial markers implanted in the
thoracic spine.
Case presentation: Our patient was a 47-year-old African-American man who presented to our hospital with a
history of several months of increasing left arm pain, chest pain, dyspnea on exertion, occasional dry cough, and
weight loss. He was found to have stage IIIA T4, N0, M0 lung cancer with vertebral body invasion. He had fiducial
markers placed in the thoracic spine for image-guided radiation treatment set-up. The patient received 74 Gy
radiation therapy with concurrent chemotherapy, and daily matching of the fiducial markers on the treatment
machine allowed for treatment of the tumor while sparing the dose to the adjacent spinal cord. With one year of
clinical follow-up, the patient has had regression of the tumor with only asymmetric soft-tissue thickening seen on
a computed tomographic scan and grade 1 dyspnea on exertion as the only side effects of the treatment.
Conclusion: Fiducial marker placement is a safe and effective technique for maximizing the accuracy and
reproducibility for radiation treatment of lesions near the spinal cord. This technique may be used in
conventionally fractionated radiation treatment regimens, such as those employed to treat a lung tumor with
vertebral body invasion, to potentially improve clinical outcomes for patients.
Introduction
The radiation tolerance of the spinal cord has tradition-
ally been a dose-limiting factor in the treatment of
spinal and paraspinal lesions. Intensity-modulated radia-
tion therapy (IMRT) planning has the ability to achieve
concave dose distributions that provide spinal cord spar-
ing even if the target lesion is only millimeters away [1].
However, these treatment plans have very steep dose
gradients, so a very high degree of precision is needed
during radiation delivery. Even very slight set-up errors
may result in significant deviation of delivery of the
planned dose [2].
Fiducial marker matching is a method of image-guided
radiation therapy (IGRT) used to maximize set-up accu-
racy. Radiopaque markers are implanted in or near the
tumor site and can be imaged on the treatment machine
and matched to the digitally reconstructed radiograph
(DRR) from the planning computed tomography (CT)
scan. The majority of published data regarding fiducial
markers in the spine have pertained to methods used in
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stereotactic radiosurgery [3-5]. Our case report describes
the application of this technique for conventionally frac-
tionated radiation treatment of a lung tumor. The appli-
cation of IGRT using fiducial markers in the spine in
our patient allowed for radiation treatment of primary
lung cancer with vertebral body invasion while limiting
the radiation dose to the adjacent spinal cord.
Case presentation
Our patient was a 47-year-old man who presented to
our hospital with a history of several months of increas-
ing left arm pain, chest pain, dyspnea on exertion, occa-
sional dry cough, and a 2.3 kg weight loss over the
course of the preceding three months. A physical exami-
nation showed 4 of 5 weakness of the left upper extre-
mity but no other abnormalities.
He underwent CT of the chest, which showed a large
left upper lobe mass measuring 6.4 cm × 3.3 cm, encas-
ing the great vessels, and invading the T3 vertebral body
(Figure 1). A video-assisted thoracoscopic biopsy of the
left upper lobe mass was positive for non-small-cell car-
cinoma. Multiple mediastinal lymph nodes, including
stations L2, L4, L5, and L7, sampled negative for tumor.
A positron emission tomography (PET) scan showed
hypermetabolic uptake in the mass but no mediastinal
or distant metastases.
The patient was diagnosed with stage IIIA T4, N0, M0
lung cancer on the basis of the AJCC Cancer Staging
Manual, Seventh Edition, staging system criteria [6]. He
was offered enrollment in Radiation Therapy Oncology
Group (RTOG) protocol 0617, and he consented. He
was randomized to receive 74 Gy of radiation therapy
using conventional daily fractions of 2 Gy with
concurrent carboplatin and paclitaxel, followed by con-
solidation carboplatin and paclitaxel.
He was evaluated by an orthopedic surgeon (JH) for
implantation of fiducial markers for IGRT because of
the proximity of the tumor to the spinal cord. Markers
were placed in the operating room with fluoroscopic
guidance. A commercially available fiducial marker kit
(CIVCO Medical Solutions, Kalona, IA, USA) was used,
with 1.2 mm × 3 mm gold markers pre-loaded in 17-
gauge sterile placement needles. The patient was sedated
using general anesthesia. A 13-gauge Jamshidi bone
marrow biopsy needle (CareFusion Corp., San Diego,
CA, USA) Verified. was inserted into the pedicle of the
T2 vertebral body. The pre-loaded needle containing the
fiducial marker was inserted through the vertebroplasty
trochar, and the gold marker was deployed into the
bone (Figures 2 and 3). Bone wax was used to secure
the markers in place. This procedure was repeated for
the T3 and T4 vertebral bodies. The patient was then
discharged to home. The only side effect he reported
from the procedure was mild pain at the surgical sites,
which lasted for three days and was controlled with
over-the-counter pain medications.
The patient underwent CT simulation for radiation
therapy planning with the use of a custom Alpha Cradle
foam mold and wingboard (Smithers Medical Products,
Inc., North Canton, OH, USA) Verified for immobiliza-
tion. CT scans of the patient were taken during inspira-
tion, expiration, and free breathing. CT simulation
images were fused with PET images to aid in target deli-
neation. Gross tumor volume was outlined during
inspiration, expiration, and free breathing scanning and
Figure 1 Pre-treatment computed tomographic scan. Figure 2 Anteroposterior view of fiducial marker placement.
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fused to form an integrated target volume. A margin of
expansion of 5 mm was used to create a clinical target
volume (CTV). An additional expansion of 5 mm was
used to create a planning target volume (PTV). The
CTV and PTV margins were decreased in the areas of
bone to limit microscopic disease extension and organ
motion in this area.
A five-beam IMRT treatment plan was devised to pro-
vide 95% coverage of the PTV with the prescription
dose of 74 Gy delivered at 2 Gy per fraction. The maxi-
mum spinal cord dose was 48.54 Gy, with a concave
dose distribution and tight dose fall-off in the area of
vertebral body invasion. Figure 4 demonstrates the
sharp fall-off from the treatment dose of 74 Gy (red) to
the approximate spinal cord tolerance dose of 50 Gy
(purple). The volume of lung receiving 20 Gy was 17%.
The treatment plan, including lung, heart, and
esophagus dose parameters, was within the specifica-
tions of the RTOG 0617 protocol.
Treatment was delivered on a Trilogy™ machine
(Varian Medical Systems, Inc., Palo Alto, CA, USA)
using daily kilovoltage (KV) imaging, which helped us to
clearly visualize the fiducial markers (Figure 5). The
position of the fiducial markers was marked on the DRR
and superimposed on the KV image taken on the treat-
ment machine, and appropriate shifts were made (Fig-
ures 6 and 7). Corrections were made in the vertical,
longitudinal, and latitudinal directions as indicated. The
range, median, and mean values of shifts are reported in
Table 1. Migration of fiducial markers was not noted
during the patient’s treatment.
The patient developed improvement in left arm pain
and strength three weeks into radiation treatment. He
developed grade 2 esophagitis toward the end of radia-
tion treatment, which was controlled with diet modifica-
tion and sucralfate as needed. His esophagitis resolved
four weeks after treatment was completed.
A CT scan of the chest and abdomen obtained 10
months after radiation treatment showed stable soft-tis-
sue asymmetry in the mediastinum, with no evidence of
recurrent or metastatic disease (Figure 8). At his one-
year follow-up visit, the patient reported grade 1 dys-
pnea on exertion but was otherwise asymptomatic.
Discussion
IGRT has emerged as a method of improving radiation
treatment accuracy for tumors near the spinal cord.
Three forms of IGRT for this purpose have been
described in the literature: cone-beam CT (CBCT), KV
X-ray imaging, and fiducial marker matching.
Figure 3 Lateral view of fiducial marker placement.
Figure 4 Radiation dose distribution.
Figure 5 Kilovoltage image of fiducial markers (blue arrows)
(anteroposterior view).
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CBCT involves use of a CT scan that can be taken on
the treatment machine. The tumor volume or normal
structures on the CBCT scan are then matched with the
treatment-planning CT scan, and appropriate shifts can
be made. Kim et al. [7] used CBCT to set up single-frac-
tion stereotactic body radiotherapy for spinal treatments
and found that it provided precise target localization
with accuracy within 2 mm.
KV X-ray imaging involves the use of orthogonal X-
ray images that can be taken in the treatment room.
These images have a higher resolution than traditionally
used megavoltage (MV) images and allow for matching
of patient anatomy to bony landmarks on a DRR. Yin et
al. [8] at Henry Ford Hospital have used KV X-ray ima-
ging with anatomy matching to vertebral bodies for
intensity-modulated spinal radiosurgery and found that
patient motion could be reduced to within 3 mm when
coupled with good immobilization.
Fiducial markers have been used successfully in spinal
radiosurgery at a number of institutions, including the
University of Pittsburgh [3] and Stanford University [4].
The implantation of markers involves an invasive proce-
dure with associated risk. Gerstzen et al. [5] reported a
series of spinal radiosurgery procedures where fiducial
tracking was used in 30 cases, and they reported one
durotomy secondary to the marker implant procedure.
Movement, or migration of markers, can also interfere
with the use of fiducial markers for accurate treatment
set-up. Shirato et al. [9] reported marker migration in
one of three patients who underwent transcutaneous
insertion of spinal markers for radiotherapy.
However, there are data suggesting that there may be
increased accuracy of fiducial markers with the use of
other forms of IGRT. Watchman et al. [10] compared
KV X-ray imaging and fiducial marker matching for the
set-up of 18 treatment fractions of stereotactic spinal
radiotherapy. They found that matching to implanted
markers was consistently more accurate, by
Figure 6 Matching of digital reconstructed radiograph to
kilovoltage image using fiducial markers (anteroposterior
view).
Figure 7 Matching of digital reconstructed radiograph to
kilovoltage image (lateral view).
Table 1 Daily shifts at treatment set-up (in centimeters)
Direction Range Mean Median
Vertical 0 to 0.7 0.2 0.2
Longitudinal 0.4 to 1.3 0.9 0.8
Latitudinal 0.3 to 1.0 0.6 0.5
Figure 8 Computed tomographic scan obtained 10 months
after treatment.
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approximately 0.5 mm, which also led to significant
sparing of the spinal cord dose.
Fiducial markers carry several practical advantages.
The markers can be clearly visualized on MV imaging
(Figure 9). Some centers that may not have newer mod-
alities such as KV imaging or CBCT available can still
use MV imaging for the daily set-up to fiducial markers.
The daily matching process takes only a few minutes for
each patient, so it can be implemented in busy clinical
departments with minimal impact on staffing needs and
machine time. The use of spinal markers also limits the
possibility of human error during the matching process,
such as matching to the wrong vertebral body, which
can occur when using other forms of IGRT.
The case of our patient shows an extension of this
technique from stereotactic radiosurgery to convention-
ally fractionated radiation therapy. Patients who have
spinal or paraspinal tumors who are not candidates for
radiosurgery because of tumor factors such as large
tumor size or other clinical reasons (such as indications
for concurrent chemotherapy) may benefit from the use
of spinal fiducial markers for conventionally fractionated
radiation therapy.
Conclusions
Fiducial marker placement is a safe and effective techni-
que for maximizing the accuracy and reproducibility of
radiation treatment to lesions near the spinal cord. The
procedure can be performed on an out-patient basis and
with little discomfort to the patient. This technique can
be used in combination with IMRT in conventionally
fractionated radiation therapy to potentially improve
clinical outcomes for patients.
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Figure 9 Megavoltage image of fiducial markers (blue arrows)
(anteroposterior view).
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